Clinical trial
Doxorubicin in Treating Women With Advanced Breast Cancer
NCT00003165 · University of Glasgow, Other · Unknown status
Key facts
| NCT number | NCT00003165 |
|---|---|
| Title | Doxorubicin in Treating Women With Advanced Breast Cancer |
| Official title | A Phase II Trial of PK1 in Women With Advanced Breast Cancer |
| Lead sponsor | University of Glasgow, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | doxorubicin-HPMA conjugate |
| Enrollment | 25 |
| Start date | Dec 1, 1997 |
| First posted | Apr 30, 2004 |
| Last update posted | Dec 19, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: